Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias

<i>Background and Objectives</i>: Tachycardia is a common cardiovascular disease. Drugs blocking β1-adrenergic receptors (ADRB1) are used in the therapy of arrhythmogenic heart diseases. Disease-related polymorphisms can be observed within the <i>ADRB1</i> gene. The two most...

Full description

Bibliographic Details
Main Authors: Ewa Moric-Janiszewska, Sławomir Smolik, Lesław Szydłowski, Małgorzata Kapral
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/12/2057
_version_ 1797380166635225088
author Ewa Moric-Janiszewska
Sławomir Smolik
Lesław Szydłowski
Małgorzata Kapral
author_facet Ewa Moric-Janiszewska
Sławomir Smolik
Lesław Szydłowski
Małgorzata Kapral
author_sort Ewa Moric-Janiszewska
collection DOAJ
description <i>Background and Objectives</i>: Tachycardia is a common cardiovascular disease. Drugs blocking β1-adrenergic receptors (ADRB1) are used in the therapy of arrhythmogenic heart diseases. Disease-related polymorphisms can be observed within the <i>ADRB1</i> gene. The two most important are Ser49Gly and Arg389Gly, and they influence the treatment efficacy. The family of the cytochrome P450 system consists of the isoenzyme CYP2D6 (Debrisoquine 4-hydroxylase), which is involved in phase I metabolism of almost 25% of clinically important drugs, including antiarrhythmic drugs. A study was conducted to detect the <i>ADRB1</i> and <i>CYP2D6</i> gene polymorphisms. <i>Materials and Methods</i>: The material for the test was whole blood from 30 patients with ventricular and supraventricular tachycardia and 20 controls. The samples were obtained from the Department of Pediatric Cardiology. The first to be made was the extraction of DNA using a GeneMATRIX Quick Blood DNA Purification Kit from EURx. The selected <i>ADRB1</i> and <i>CYP2D6</i> gene polymorphisms were detected by high-resolution melting polymerase chain reaction (HRM-PCR) analysis. <i>Results</i>: Based on the analysis of melt profile data for each PCR product, the identification of polymorphisms was carried out. Heterozygotes and homozygotes were found in the examined alleles. <i>Conclusions</i>: The frequency of the Arg389Gly polymorphism differs statistically significantly between the control group and patients with supraventricular and ventricular arrhythmias, as well as between these two groups of patients. Moreover, the Arg389Gly polymorphism was statistically more prevalent in the group of girls with SVT arrhythmia compared to girls with VT. A few carriers of homozygous and heterozygous systems of the S49G polymorphism were detected among patients with arrhythmias, as well as control group. The percentage of individuals carrying the <i>CYP2D6 4</i> allele as either homozygous or heterozygous was observed in the study and control groups. The high prevalence of the <i>CYP2D6*4</i> allele carriers in both groups prompts the optimization of beta-1 blocker therapy.
first_indexed 2024-03-08T20:33:27Z
format Article
id doaj.art-fcaf58ee24c341e680e322986ae12216
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-08T20:33:27Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-fcaf58ee24c341e680e322986ae122162023-12-22T14:23:40ZengMDPI AGMedicina1010-660X1648-91442023-11-015912205710.3390/medicina59122057Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular ArrhythmiasEwa Moric-Janiszewska0Sławomir Smolik1Lesław Szydłowski2Małgorzata Kapral3Department of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8B, 41-200 Sosnowiec, PolandDepartment of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8B, 41-200 Sosnowiec, PolandDepartment of Pediatric Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Medyków 16, 40-752 Katowice, PolandDepartment of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8B, 41-200 Sosnowiec, Poland<i>Background and Objectives</i>: Tachycardia is a common cardiovascular disease. Drugs blocking β1-adrenergic receptors (ADRB1) are used in the therapy of arrhythmogenic heart diseases. Disease-related polymorphisms can be observed within the <i>ADRB1</i> gene. The two most important are Ser49Gly and Arg389Gly, and they influence the treatment efficacy. The family of the cytochrome P450 system consists of the isoenzyme CYP2D6 (Debrisoquine 4-hydroxylase), which is involved in phase I metabolism of almost 25% of clinically important drugs, including antiarrhythmic drugs. A study was conducted to detect the <i>ADRB1</i> and <i>CYP2D6</i> gene polymorphisms. <i>Materials and Methods</i>: The material for the test was whole blood from 30 patients with ventricular and supraventricular tachycardia and 20 controls. The samples were obtained from the Department of Pediatric Cardiology. The first to be made was the extraction of DNA using a GeneMATRIX Quick Blood DNA Purification Kit from EURx. The selected <i>ADRB1</i> and <i>CYP2D6</i> gene polymorphisms were detected by high-resolution melting polymerase chain reaction (HRM-PCR) analysis. <i>Results</i>: Based on the analysis of melt profile data for each PCR product, the identification of polymorphisms was carried out. Heterozygotes and homozygotes were found in the examined alleles. <i>Conclusions</i>: The frequency of the Arg389Gly polymorphism differs statistically significantly between the control group and patients with supraventricular and ventricular arrhythmias, as well as between these two groups of patients. Moreover, the Arg389Gly polymorphism was statistically more prevalent in the group of girls with SVT arrhythmia compared to girls with VT. A few carriers of homozygous and heterozygous systems of the S49G polymorphism were detected among patients with arrhythmias, as well as control group. The percentage of individuals carrying the <i>CYP2D6 4</i> allele as either homozygous or heterozygous was observed in the study and control groups. The high prevalence of the <i>CYP2D6*4</i> allele carriers in both groups prompts the optimization of beta-1 blocker therapy.https://www.mdpi.com/1648-9144/59/12/2057genetic polymorphismβ-blockerspharmacogenetics
spellingShingle Ewa Moric-Janiszewska
Sławomir Smolik
Lesław Szydłowski
Małgorzata Kapral
Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
Medicina
genetic polymorphism
β-blockers
pharmacogenetics
title Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
title_full Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
title_fullStr Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
title_full_unstemmed Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
title_short Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
title_sort associations between selected i adrb1 i and i cyp2d6 i gene polymorphisms in children with ventricular and supraventricular arrhythmias
topic genetic polymorphism
β-blockers
pharmacogenetics
url https://www.mdpi.com/1648-9144/59/12/2057
work_keys_str_mv AT ewamoricjaniszewska associationsbetweenselectediadrb1iandicyp2d6igenepolymorphismsinchildrenwithventricularandsupraventriculararrhythmias
AT sławomirsmolik associationsbetweenselectediadrb1iandicyp2d6igenepolymorphismsinchildrenwithventricularandsupraventriculararrhythmias
AT lesławszydłowski associationsbetweenselectediadrb1iandicyp2d6igenepolymorphismsinchildrenwithventricularandsupraventriculararrhythmias
AT małgorzatakapral associationsbetweenselectediadrb1iandicyp2d6igenepolymorphismsinchildrenwithventricularandsupraventriculararrhythmias